Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Ohlsson, Arne ^a   Lacy, Janet B ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTRANSFUSION; GAMIMMUNE; GAMMUMINE N; HUMAN IMMUNOGLOBULIN; IGVENA; IMMUNOGLOBULIN; PLACEBO; IMMUNOLOGIC FACTOR;

BRAIN HEMORRHAGE; DEPRESSED BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ELEVATED BLOOD PRESSURE; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFANT MORTALITY; INFECTION; LENGTH OF STAY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MENINGITIS; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY TRACT INFECTION; CROSS INFECTION; INFANT, PREMATURE, DISEASES; META ANALYSIS; NEWBORN;

CROSS INFECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84891643048     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000361.pub3     Document Type: Review

References (78)

1. Atici A, Satar M, Karabay A, Yilimaz M. Intravenous immunoglobulin for prophylaxis of nosocomial sepsis. Indian Journal of Pediatrics 1996;63:517-21.
2. Baker CJ, Melish ME, Hall RT, et al. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. New England Journal of Medicine 1992;327:213-9.
3. Bussel JB. Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial. Reviews of Infectious Diseases 1990;12:S457-62.
4. Chirico G, Rondini G, Plebani A, Chiara A, Massa M, Ugazio AG. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. Journal of Pediatrics 1987;110:437-42.
5. Chou Y-H, Yau K-I T. The use of prophylactic intravenous immunoglobulin therapy in very low birthweight infants. Chang Gung Medical Journal 1998;21:371-6.
6. Christensen RD, Hardman T, Thornton J, Hill HR. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates. Journal of Perinatology 1989;9:126-30.
7. Clapp DW, Kliegman RM, Baley JE, et al. Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. Journal of Pediatrics 1989;115:973-8.
8. Conway SP, Ng PC, Howel D, Maclain B, Gooi HC. Prophylactic intravenous immunoglobulin in pre-term infants: a controlled trial. Vox Sanguinis 1990;59:6-11.
9. Didato MA, Gioeli R, Priolisi A. The use of intravenous gamma-globulin for prevention of sepsis in pre-term infants. Helvetica Paediatrica Acta 1988;43:283-94.
10. Fanaroff AA, Korones SB, Wright LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. New England Journal of Medicine 1994;330:1107-13.
11. Fanaroff-1 Phase 1 of Fanaroff 1994. New England Journal of Medicine 1994; Vol. 330:1107-13.
12. Haque KN, Zaidi MH, Haque SK, Bahakim H, El-Hazmi M, El-Swailam M. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatric Infectious Disease 1986;5:622-5.
13. Magny JF, Bremard-Oury C, Brault D, Menguy C, Voyer M, Landais P, et al. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double-blind study. Pediatrics 1991;88:437-43.
14. Ratrisawadi V, Srisuwanporn T, Puapondh Y. Intravenous immunoglobulin prophylaxis for infection in very low birth-weight infants. Journal of the Medical Association of Thailand 1991;74:14-8.
15. Sandberg K, Fasth A, Berger A, Eibl M, Isacson K, Lisebka A, et al. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. Journal of Pediatrics 2000;137:623-8.
16. Spady DW, Pabst HF, Byrnes P. Intravenous immunoglobulin (IVIG) shortens stay for low birth weight infants [abstract]. Pediatr Research 1994;35:304A.
17. Stabile A, Sopo SM, Romanelli V, Pastore M, Pesaresi MA. Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants. Archives of Disease in Childhood 1988;63:441-3.
18. Tanzer F, Yazar N, Hakgudener Y, Kafali G. Intravenous immunoglobulin for sepsis prevention in preterm infants. Turkish Journal of Pediatrics 1997;39:341-5.
19. Van Overmeire B, Bleyaert S, van Reempts PJ, van Acker KJ. The use of intravenously administered immunoglobulins in the prevention of severe infection in very low birth weight neonates. Biology of the Neonate 1993;64:110-5.
20. Weisman LE, Stoll BJ, Kueser TJ, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. Journal of Pediatrics 1994;125:922-30.
21. Acunas BA, Peakman M, Liossis G, et al. Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis. Archives of Disease in Childhood 1994;70:F182-7.
22. Adhikari M, Wesley AG, Fourie PB. Intravenous immunoglobulin prophylaxis in neonates on artificial ventilation. South African Medical Journal 1996;86:542-5.
23. Kacet N, Gremillet C, Zaoui C, et al. Prevention of late-onset infections in preterm infants with intravenous gamma-globulin: a randomized clinical trial [abstract ]. European Journal of Pediatrics 1991;150:604.
24. Kinney J, Mundorf L, Gleason C, et al. Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates. American Journal of Diseases of Children 1991;145:1233-8.
25. Lelik MP, Efanova EA. Prevention of nosocomial infections in newborns at artificial lung ventilation. Anesteziologiia i Reanimatologiia 2004;May-June(3):41-3.
26. Malik S, Giacoia GP, West K, Miller G. Intravenous immunoglobulin (IVIG) to prevent infections in infants with bronchopulmonary dysplasia (BPD) [abstract]. Pediatric Research 1990;27:273A.
27. Monintja HE. Investigation on immunoglobulin fortification in preventing infections in the newborn. Paediatrica Indonesiana 1989;29:91-6.
28. Baker CJ. New uses of intravenous immune globulin in newborn infants. Journal of Clinical Immunology 1990;10:47S-55S.
29. Baker CJ, Rench MA, Noya FJD, Garcia-Prats JA, and the Neonatal IVIG Study Group. Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. Reviews of Infectious Diseases 1990;12:S463-9.
30. Baley JE. Neonatal sepsis: the potential for immunotherapy. Clinics in Perinatology 1988;15:755-71.
31. Baley JE, Fanaroff AA. Neonatal infections. Part 2: Specific infectious diseases and therapies. In: Sinclair J, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:496-506.
32. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187:1-7.
33. Berger M. Use of intravenously administered immune globulin in newborn infants: prophylaxis, treatment, both, or neither. Journal of Pediatrics 1991;118:557-9.
34. Bortolussi R, Fischer GW. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Pediatric Research 1986;20:175-8.
35. Bortolussi R. Potential for intravenous gamma-globulin use in neonatal gram-negative infection: an overview. Pediatric Infectious Diseases 1986;5:S198-200.
36. Bussel JB. Neonatal uses of intravenous immunoglobulin. American Journal of Pediatric Hematol/Oncology 1990;12:505-9.
37. Consensus Working Group. Present and future uses of IVIG: a Canadian multidisciplinary consensus-building initiative. Canadian Journal of Allergy and Clinical Immunology 1997;2:176-208.
38. Fischer GW, Hemming VG, Hunter KW, et al. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies. Pediatric Infectious Disease 1986;5:S171-5.
39. Fischer GW. Therapeutic uses of intravenous gammaglobulin for pediatric infections. Pediatric Clinics of North America 1988;35:517-33.
40. Fischer GW, Weisman LE. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics. Scandinavian Journal of Infectious Diseases 1990;73 Suppl:17-21.
41. Fischer GW, Hemming VG, Gloser HP, Bachmyer H, von Pilar CE, Wilson SR, et al. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Reviews of Infectious Diseases 1990;12:S483-91.
42. Fischer GW. Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies. Journal of Clinical Immunology 1990;10:40S-6S.
43. Gonzalez LA, Hill HR. The current status of intravenous gamma-globulin use in neonates. Pediatric Infectious Disease Journal 1989;8:315-22.
44. Hammarstrom L, Smith CIE. The use of intravenous IgG as prophylaxis and for treatment of infections. Infection 1990;18:314-24.
45. Haque KH. Does the commercial type of IVIG used make a difference?. Pediatrics 1992;89:806-7.
46. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
47. Hill HR. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection. Pediatric Infectious Disease Journal 1993;12:549-59.
48. Hill RH. Is prophylaxis of neonates with intravenous immunoglobulin beneficial. American Journal of Diseases of Children 1991;145:1229-30.
49. Hill HR. The role of intravenous immunoglobulin in the treatment and prevention of neonatal bacterial infection. Seminars in Perinatology 1991;15:41-6.
50. Hobbs JR, Davis JA. Serum IgG-globulin levels and gestational age in premature babies. Lancet 1967;I:757-9.
51. Irani SF, Wagle SU, Deshpande PG. Role of intravenous immunoglobulin in prevention and treatment of neonatal infection. Indian Pediatrics 1991;28:443-9.
52. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997;99:e2.
53. Johnston RB. Immunotherapy and immunoprophylaxis in the newborn infant: the need for definitive trials. Reviews of Infectious Diseases 1990;12:S392-3.
54. Kliegman RM, Clapp DW, Berger M. Targeted immunoglobulin therapy for the prevention of neonatal infections. Reviews of Infectious Diseases 1990;12:S443-56.
55. Kliegman RM, Clapp DW. Rational principles for immunoglobulin prophylaxis and therapy for neonatal infections. Clinics in Perinatology 1991;18:303-324.
56. Kyllonen KS, Clapp W, Kliegman RM, Baley JE, Shenker N, Fanaroff AA, et al. Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infants. Journal of Pediatrics 1989;115:1013-6.
57. Lacy JB, Ohlsson A. Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses. Archives of Disease in Childhood 1995;72:F151-5.
58. Magny J-F. Les immunoglobulines sont-elles utiles dans le traitment des infections neonatales?. La Revue du Praticien 1991;41:1368-70.
59. Noya FJD, Baker CJ. Intravenously administered immune globulin for premature infants: a time to wait. Journal of Pediatrics 1989;115:969-71.
60. Papile LA, Munsick-Bruno G, Schafer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. Journal of Pediatrics 1983;103:273-7.
61. Rondini G, Chirico G, Ugazio AG. Intravenous immunoglobulin for prophylaxis of infection in preterm infants. Developmental Pharmacology and Therapeutics 1991;17:144-9.
62. Salzer HR, Weninger M, Pollak A, Kolmer M. Prophylactic immunoglobulin (IG) treatment in infants less than 30 weeks gestation-a meta analysis [abstract]. European Journal of Pediatrics 1991;150:604.
63. Siber GR. Immune globulin to prevent nosocomial infections. New England Journal of Medicine 1992;327:269-71.
64. Stabile A, Sopo SM, Pastore M, Pesaresi MA. Intravenous immune globulin doses and infection prophylaxis in very low birth weight neonates. Journal of Pediatrics 1989;114:168.
65. Stiehm RE, Fudenberg HH. Serum levels of immune globulins in health and disease: a survey. Pediatrics 1966;37:715-27.
66. Stiehm ER. Intravenous immunoglobulins in neonates and infants: an overview. Pediatric Infectious Disease 1986;5:S217-9.
67. Stiehm ER. Role of immunoglobulin therapy in neonatal infections: where we stand today. Reviews of Infectious Diseases 1990;12:S439-42.
68. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics 1996;129:63-71.
69. Weisman LE, Fischer GW, Hemming VG, Peck CC. Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates. Pediatric Infectious Disease 1986;5:S185-8.
70. Weisman LE, Cruess DF, Fischer GW. Current status of intravenous immunoglobulin in preventing or treating neonatal bacterial infections. Clinical Reviews in Allergy 1992;10:13-28.
71. Weisman LE, Cruess DF, Fischer GW. Standard versus hyperimmune immunoglobulin in preventing or treating neonatal bacterial infections. Clinics in Perinatology 1993;20:211-24.
72. Weisman LE, Cruess DF, Fischer GW. Opsonic activity of commercially available standard intravenous immunoglobulin preparations. Pediatric Infectious Disease Journal 1994;13:1122-5.
73. Whitelaw A. Treatment of sepsis with IgG in very low birthweight infants. Archives of Disease in Childhood 1990;65:347-8.
74. Wolach B. Neonatal sepsis: pathogenesis and supportive therapy. Seminars in Perinatology 1997;21:28-38.
75. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000361]
76. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000361]
77. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD000361.pub2]
78. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000361]